Marvin Johnson serves as Executive at MARINUS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Marvin Johnson has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 18, 2024 involved receiving (via award) 2,300 shares valued at $0.
Marvin Johnson currently holds 14,100 shares of MARINUS PHARMACEUTICALS, INC. (MRNS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marvin Johnson has been a net neutral trader of MRNS stock. They have purchased $0 and sold $0 worth of shares.
Marvin Johnson's most recent insider trade was on Jun 18, 2024, when they sold 2,300 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 17, 2023 | MRNS | $0 | Award | 7,200 | $N/A | Discretionary |